Coronary artery bypass grafting in patients with systemic lupus erythematosus

Z Kardiol. 2003 Mar;92(3):219-21. doi: 10.1007/s00392-003-0909-4.

Abstract

Cardiac involvement in patients with systemic lupus erythematosus (SLE) is common. The natural history of the cardiovascular manifestations has been altered by systemic corticosteroids used for the treatment of SLE; thus, young patients with SLE may suffer from angina and myocardial infarction. The surgical problems and special requirements in patients with SLE are discussed. CAD is one of the major complications limiting the prognosis of the patient with SLE. In the future, a large number of SLE patients may be candidates for myocardial revascularization. In our opinion, total autogenous arterial bypass grafting is advised and intraoperative biopsies of the LIMA are meaningful in patients with SLE.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Cohort Studies
  • Coronary Artery Bypass*
  • Coronary Disease / diagnosis
  • Coronary Disease / etiology*
  • Coronary Disease / surgery
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Male
  • Prospective Studies
  • Risk Factors

Substances

  • Adrenal Cortex Hormones